$20m in financing for blood-based bowel cancer test

Venture capital firm OneVentures has closed a $19.7 million financing round for Clinical Genomics, an Australian company set to launch its next-generation blood-based diagnostic tool for colorectal cancer.

Learn More

Posted in — LabOnline


You may also like

22 March 2016

$20m in financing for blood-based bowel cancer test

01 November 2013

Hatchtech hardly a head-scratcher for investors

10 February 2015

Vaxxas raises $25m in Series B financing

View All

Ventured. Gained.

Subscribe to our Newsletter for the latest updates from 1V.

decor decor decor
decor decor decor decor decor